新文化(300336.SZ):擬變更會計師事務所
格隆匯 3 月 8日丨新文化(300336.SZ)公佈,公司於2021年3月8日召開第四屆董事會第十八次會議、第四屆監事會第十六次會議,審議通過了《關於變更會計師事務所的議案》,同意聘任中興華會計師事務所(特殊普通合夥)(“中興華”)為公司2020年度審計機構,並提交公司2021年第二次臨時股東大會審議。
公司原2020年度審計機構為大信會計師事務所(特殊普通合夥)(“大信”)。因公司與大信就審計工作安排上的原因,預計無法在公司指定時間內完成公司2020年度審計工作,為保證公司審計工作順利開展,經綜合評估,提議改聘中興華擔任公司2020年度審計機構,為公司提供審計服務,聘期一年。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.